STUDY SEARCH RESULTS

1 study found for your search request:  V116-008

Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
Condition: Pneumococcal infection
Minimum Age: 18 years, Maximum Age: 64 years
Gender: All
Study ID: NCT05696080
Status: Completed




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site